Stockreport

Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance [Yahoo! Finance]

Clover Health Investments, Corp. - Class A Common stock  (CLOV) 
PDF Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year Company well positioned to invest in membership growth and Clov [Read more]